| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.1979.03630380035014 |
| P698 | PubMed publication ID | 760684 |
| P50 | author | Vecihi Batuman | Q37837396 |
| P2093 | author name string | Wedeen RP | |
| Malik DK | |||
| P433 | issue | 1 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 53-57 | |
| P577 | publication date | 1979-01-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Detection and treatment of occupational lead nephropathy | |
| P478 | volume | 139 |
| Q28575452 | Activation profiles of HSPA5 during the glomerular mesangial cell stress response to chemical injury |
| Q43491728 | An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. |
| Q28393686 | Associations of lead biomarkers with renal function in Korean lead workers |
| Q28385956 | Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey |
| Q28386914 | Blood lead level and measured glomerular filtration rate in children with chronic kidney disease |
| Q34660836 | Blood pressure and blood lead concentration in bus drivers |
| Q29620343 | Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms |
| Q70386141 | Bone lead in dialysis patients |
| Q68523303 | Case report 445. Bilateral acromioclavicular gouty arthritis with pseudo-tumor of the outer end of the right clavicle: saturnine gout |
| Q90589154 | Chronic Environmental and Occupational Lead Exposure and Kidney Function among African Americans: Dallas Lead Project II |
| Q39659877 | Chronic low-level lead exposure. Its role in the pathogenesis of hypertension |
| Q37800005 | Chronic renal failure from lead: myth or evidence-based fact? |
| Q71944025 | Detection of Occupational Lead Nephropathy Using Early Renal Markers |
| Q83207446 | Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes |
| Q33962867 | Environmental lead exposure and urate excretion in the general population |
| Q45163467 | Experimental model of lead nephropathy. I. Continuous high-dose lead administration |
| Q46255602 | Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA) |
| Q34079714 | Exposure to metals |
| Q28386059 | Global dimensions of chronic kidney disease of unknown etiology (CKDu): a modern era environmental and/or occupational nephropathy? |
| Q33577936 | Health significance of cadmium induced renal dysfunction: a five year follow up. |
| Q28391722 | Health status of cable splicers with low-level exposure to lead: results of a clinical survey |
| Q34538110 | Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project |
| Q35561022 | Impact of developmental lead exposure on splenic factors |
| Q34847149 | Increased risk of proteinuria among a cohort of lead-exposed pregnant women |
| Q33583692 | Kidney effects in long term exposed lead smelter workers |
| Q66914211 | Lead Enhancement of Lithium-Induced Polydipsia |
| Q35560832 | Lead absorption and renal dysfunction in a South African battery factory |
| Q41158000 | Lead and cadmium at very low doses affect in vitro immune response of human lymphocytes |
| Q70427290 | Lead and the gouty kidney |
| Q39752409 | Lead intoxication. |
| Q69793850 | Lead nephropathy |
| Q70314849 | Lead nephropathy |
| Q71675410 | Lead nephropathy and gout |
| Q37454378 | Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease |
| Q45007145 | Lead poisoning in adults from renovation of an older home |
| Q67703934 | Lead, a major environmental pollutant, is immunomodulatory by its differential effects on CD4+ T cell subsets |
| Q23912272 | Lead-related nephrotoxicity: a review of the epidemiologic evidence |
| Q28383350 | Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead |
| Q24169892 | Metal exposure and common chronic diseases: a guide for the clinician |
| Q54647570 | Occupational exposure to lead: Effects on renal function |
| Q40210363 | Occupational renal disease |
| Q60457310 | Pharmacokinetics of meso-2,3- dimercaptosuccinic acid in patients with lead poisoning and in healthy adults |
| Q28391045 | Possibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sites |
| Q44530931 | Potential lead hazards. The presence of lead in autoclave indicators |
| Q22306126 | Recommendations for medical management of adult lead exposure |
| Q69175563 | Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study |
| Q42554324 | Renal effects of environmental and occupational lead exposure |
| Q38648705 | Saturnine gout |
| Q68991464 | Search for anti-laminin antibodies in the serum of workers exposed to cadmium, mercury vapour or lead |
| Q67879503 | The Urinary Excretion of Specific Proteins in Workers Exposed to Lead |
| Q35029852 | The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study |
| Q93557615 | The proteinuria of industrial lead intoxication |
| Q35036922 | Toxic wastes and kidney disease: research needs |
| Q71061132 | Ultrastructural changes in the kidneys of rabbits treated with lead acetate |
| Q23918293 | Unanswered questions in metal chelation |
Search more.